Right Analysis-wrong conclusion: Obese youth with higher BP are at risk for target organ damage.
Right Analysis-wrong conclusion: Obese youth with higher BP are at risk for target organ damage.
复制标题
正确的分析-错误的结论:血压较高的肥胖青少年存在靶器官损伤的风险。
DOI:
10.1093/ajh/hpv009
复制
发表时间:
2015
影响因子:
3.2
通讯作者:
Falkner,Bonita
中科院分区:
文献类型:
--
作者:
Urbina,ElaineM;Falkner,Bonita
See ARTICLE page 672 The sphygmomanometer was invented by Karl Ritter in the 1880s 1 and was later adopted as a routine vital sign in physical examination since extremely high or low blood pressure (BP) levels were found to indicate presence of disease. In an historical review, Kotchen 2 tracked the role of the insurance industry in recognizing a relationship between BP and mortality. In the early 1900s, BP measurement became part of life insurance examinations, and actuarial data developed from that era showed an effect of elevated BP on life expectancy. However, it was not until the 1950s that data from the Framingham Heart Study demonstrated that modest elevations of BP were predictive of future adverse cardiovascular (CV) events. 3 The study confirmed that high BP is a risk factor for CV disease and predicts subsequent morbidity. Many later studies replicated these findings and demonstrated that as BP increases there is a linear increase in CV risk, without a threshold effect (ie, a clear cut-point at which lower levels of BP are “safe”). 4 These historical observations are important to remember because it is not the BP level itself, which confers morbidity and mortality, but it is the harm the BP elevation is causing to important body organs that leads to CV events. In fact, BP-related target organ damage such as elevated left ventricular mass (LVM), increased carotid intima-media thickness (cIMT), and pulse wave velocity (PWV) are predictors of hard CV events in adults, even after adjusting for other CV risk factors. 5–7 The precise level of BP that elevates risk for future adverse events in children is less clear. With development of normative BP data on asymptomatic healthy children, it was recognized that BP levels in children and adolescents are considerably lower than in adults; and there is a progressive increase in BP level that corresponds to childhood growth and development. In adults, there are long-term outcome data that link a BP level (eg, 140/90 mm Hg) with high risk for subsequent events such as stroke, heart failure, kidney failure, or death, thus providing a numerical BP level to predict heightened risk. However, no such outcome data that link a BP level with heightened risks are available in childhood. Moreover, BP data in healthy children demonstrate a shift in the normative BP distribution curve according to age, sex, and height. For these reasons, since the late 1970s, hypertension in childhood has been defined statistically as a BP level that matches the extreme portion of the normal distribution. Therefore, hypertension in childhood is defined as BP level that is≥ 95th percentile of the age, sex, and heightadjusted BP distribution. 8 Thus, hypertension in children is defined statistically and, unlike adult hypertension, is not based on outcomes. Whether this childhood definition of hypertension accurately estimates risk for later CV events or for underlying CV injury has never been confirmed. The association of obesity with higher BP has been has well established in both adults and children. Several epidemiologic and clinical reports describe the strong association of overweight and obesity with high BP and prevalence of hypertension in childhood. 9–11 When overweight and obese children were removed from the child BP data used in the Fourth Report, 12 the BP levels at the 95th percentile were lower. 13 In the report by Schwandt et al. 14 in this issue of the journal, the authors clearly demonstrate divergence in age, height, and sex-adjusted BP distribution in normal weight vs. overweight vs. obese children. The BP distributions are considerably higher in obese children. For example, the 95th percentile for a median height 15-year …
登录
查看更多内容
影响因子:
4.9
作者:
B. Falkner
通讯作者:
B. Falkner
影响因子:
3.2
作者:
Schwandt, Peter;Scholze, Juergen E.;Haas, Gerda M.
通讯作者:
Haas, Gerda M.
DOI:
--
发表时间:
1957-04
期刊:
American journal of public health and the nation's health
影响因子:
--
作者:
T. Dawber;F. E. Moore;G. Mann
通讯作者:
T. Dawber;F. E. Moore;G. Mann
影响因子:
5
作者:
Rosner, B.;Cook, N.;Falkner, B.
通讯作者:
Falkner, B.
DOI:
10.2105/ajph.47.4_pt_2.4
发表时间:
1957-01-01
期刊:
AMER JOUR PUBL HEALTH
影响因子:
--
作者:
DAWBER, T. R.;MOORE, F. E.;MANN, G. V.
通讯作者:
MANN, G. V.